Qingdao Vland Biotech INC.

¥11.86As of Sun 8 Nov 2026, 12:00 UTC
SSE:603739Healthcare
Country China
PE (Fwd) •••
TSR 8Y CAGR (6.11%)
Div yield 0.84%
ROE 5.19%
Biotechnology
Beta (5Y) 0.53
PE TTM 40.96
TSR TTM (24.11%)
Mkt cap ¥3.001B
ROIC 3.85%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥15
26.44%
(80.38%)
Hold 9|4|8|2|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.18
0.18
0.18
0.19
4.67%
(4.93%)
(6.47%)
1.12%
Revenue¥M
220.5
227.9
233.6
246.0
0.26%
1.57%
3.97%
12.73%
Peers (US$449.8M)
Cap (US$)
PE
440.2M
212.0x
447.5M
—
Capital
TTM
5Y
10Y
Leveragex
5.025
0.056
0.054
EBIT/Intx
1.129
0.053
0.052
Own earn%
(39.21)
18.33
25.75
Sh yield%
44.58
24.89
24.80
Owners
Insiders/Inst%
6.38
74.66
Short interest%
3.58
SBC / revenue%
5.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
6–12
$1 testx
—
Incr. ROIC%
5